Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Liminatus Pharma, Inc. - Class A Common Stock
No Price
21.04.2026 08:58
Current Prices from Liminatus Pharma, Inc. - Class A Common Stock
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
LIMN
USD
21.04.2026 08:58
0,21 USD
-0,002 USD
-0,79 %
IEX
LIMN
USD
20.04.2026 19:40
0,21 USD
-0,02 USD
-9,79 %
Share Float & Liquidity
Free Float30,09 %
Shares Float8,07 M
Shares Outstanding26,83 M
Company Profile for Liminatus Pharma, Inc. - Class A Common Stock Share
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
Company Data
NameLiminatus Pharma, Inc. - Class A Common Stock
CompanyLiminatus Pharma, Inc. Class A Common Stock
